Gain a competitive edge with trusted insights and analytics
Portfolio strategy and asset selection
Gain a competitive edge and stay on top of which generics and APIs are most likely to succeed. Quickly and thoroughly research new product and company opportunities using a single source of integrated data from Cortellis Generics Intelligence, including patents, sales, pack price, consumption, Paragraph IV patent challenges, API, market share, companies and launches.
"Building and continually monitoring a differentiated product portfolio is critical for us, and Clarivate has helped us do just that, which is essential to our growth."
Partner identification and new market expansion
Building and executing a strong portfolio strategy is crucial in your quest to be first-to-market or best-in-class. Understand the market landscape and pursue new opportunities while monitoring latest regulatory guidelines.
“We have had [Cortellis Generics Intelligence] for over 15 years. With competition at an all-time high, you need a place with direct information in one spot.”
API sourcing
To succeed in today’s highly competitive environment, you need to secure new product launches earlier, find cost-effective sources of supply, and stay compliant in an ever-changing regulatory environment. Accurately identify the earliest date a drug can go generic and assess market competitiveness. Determine API suppliers’ experience and capabilities using powerful analytics incorporating market, patent, and API data generated from primary research.
“[Cortellis Generics Intelligence] is one the greatest tools for us to manage our suppliers in API business. [It] provides unique and serious data for those who are responsible in supply management, control and new product development.”
